NLRP1 and Alzheimer disease: Moreover, we also employed a panel of commercially available antibodies to identify Aβ and pTau, and the inflammasome proteins, NLRP‐1, NLRP‐3, and caspase‐1 in postmortem human brains with and without intermediate AD neuropathological changes.